Erratum: Mapping the central effects of ketamine in the rat using pharmacological MRI (Psychopharmacology DOI: 10.1007/s00213-006-0344-0);Mapping the central effects of ketamine in the rat using pharmacological MRI

Psychopharmacology

Volumn 186, Issue 1, 2006, Pages 64-81

  Littlewood, Clare L ^a   Jones, Nicholas ^a   O'Neill, Michael J ^b   Mitchell, Stephen N ^b   Tricklebank, Mark ^b   Williams, Steven C R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Anaesthesia; Microdialysis; MRI; Psychostimulant; Rat

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; KETAMINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; BLOOD OXYGENATION; BRAIN CORTEX; BRAIN MAPPING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; FRONTAL CORTEX; GLOBUS PALLIDUS; HIPPOCAMPUS; LIMBIC CORTEX; LOCOMOTION; MALE; METABOLITE; MICRODIALYSIS; NERVE CELL STIMULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SYMPTOMATOLOGY; TECHNIQUE;

EID: 33646344210     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0544-7     Document Type: Erratum

References (91)

1. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
2. Akeson J, Bjorkman S, Messeter K, Rosen I, Helfer M (1993) Cerebral pharmacodynamics of anaesthetic and subanaesthetic doses of ketamine in the normoventilated pig. Acta Anaesthesiol Scand 37:211-218
3. Albanese J, Arnaud S, Rey M, Thomachot L, Alliez B, Martin C (1997) Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology 87:1328-1334
4. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79:565-575
5. Bandettini PA, Wong EC, Hinks RS, Tikofsky RS, Hyde JS (1992) Time course EPI of human brain function during task activation. Magn Reson Med 25:390-397
6. Beckmann CF (2002) Probabilistic independant components analysis for fMRI. FMRIB Analysis Group
7. Berg-Johnsen J, Langmoen IA (1992) The effect of isoflurane on excitatory synaptic transmission in the rat hippocampus. Acta Anaesthesiol Scand 36:350-355
8. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatr 154:805-811
9. Brett M, Anton J-L, Valabreque R, Poline J-P (2002) Region of interest analysis using an SPM toolbox. Abstract presented at the 8th international conference on functional mapping of the human brain, June 2-6, 2002, Sendai, Japan. Neuroimage 16:2
10. Bristow LJ, Hutson PH, Thorn L, Tricklebank MD (1993) The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol 108:1156-1163
11. Burdett NG, Menon DK, Carpenter TA, Jones JG, Hall LD (1995) Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results. Magn Reson Imaging 13:549-553
12. Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653-661
13. Cash D, Read SJ, Lythgoe D, Williams SCR, Roberts TJ, Ireland MD, Smart SC, Hunter AJ (2003) Autoradiographic and functional MRI assessment of rat brain response to amphetamine under halothane and a-chloralose anaesthesia. J Cereb Blood Flow Metab 23:810
14. Cavazzuti M, Porro CA, Biral GP, Benassi C, Barbieri GC (1987) Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 7:806-811
15. Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50:71-83
16. Chen YC, Choi JK, Andersen SL, Rosen BR, Jenkins BG (2004) Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180(4):705-715
17. Chen YI, Choi JK, Jenkins BG (2005) Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI. Synapse 55:80-88
18. Crosby G, Crane AM, Sokoloff L (1982) Local changes in cerebral glucose utilization during ketamine anesthesia. Anesthesiology 56:437-443
19. Dawson B, Michenfelder JD, Theye RA (1971) Effects of ketamine on canine cerebral blood flow and metabolism: modification by prior administration of thiopental. Anesth Analg 50:443-447
20. de Sousa SL, Dickinson R, Lieb WR, Franks NP (2000) Contrasting synaptic actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology 92:1055-1066
21. Dixon AL, Prior M, Morris PM, Shall YB, Joseph MH, Young AM (2005) Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48:236-245
22. Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR (1998) Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787:181-190
23. Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA (1999) Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res 843:171-183
24. Ellison G (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev 20:250-267
25. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189-210
26. Grace AA (2000) Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 31:330-341
27. Harel N, Lee SP, Nagaoka T, Kim DS, Kim SG (2002) Origin of negative blood oxygenation level-dependent fMRI signals. J Cereb Blood Flow Metab 22:908-917
28. Hetzler BE, Wautlet BS (1985) Ketamine-induced locomotion in rats in an open-field. Pharmacol Biochem Behav 22:653-655
29. Hewitt KN, Shah YB, Prior MJ, Morris PG, Hollis CP, Fone KC, Marsden CA (2005) Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methyl-phenidate in a potential new rat model of attention deficit hyperactivity disorder. Psychopharmacology (Berl) 180(4):716-723
30. Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG (1999) Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology 90:174-182
31. Hlustik P, Noll DC, Small SL (1998) Suppression of vascular artifacts in functional magnetic resonance images using MR angiograms. Neuroimage 7:224-231
32. Houston GC, Papadakis NG, Carpenter TA, Hall LD, Mukherjee B, James MF, Huang CL (2001) Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magn Reson Imaging 19:905-919
33. Hunt MJ, Kessal K, Garcia R (2005) Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats. J Neurosci 25:524-531
34. Hustveit O, Maurset A, Oye I (1995) Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol 77:355-359
35. Imperato A, Scrocco MG, Bacchi S, Angelucci L (1990) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur J Pharmacol 187:555-556
36. Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, Williams SC (2005) Mapping the effects of the selective dopamine D2/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging. Neuroscience 133:315-326
37. Irifune M, Fukuda T, Nomoto M, Sato T, Kamata Y, Nishikawa T, Mietani W, Yokoyama K, Sugiyama K, Kawahara M (1997) Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Brain Res 763:281-284
38. Irifune M, Sato T, Kamata Y, Nishikawa T, Dohi T, Kawahara M (2000) Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg 91:230-236
39. Irifune M, Shimizu T, Nomoto M (1991) Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav 40:399-407
40. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4:460-463
41. Jones N, O'Neill MJ, Tricklebank M, Libri V, Williams SC (2005) Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180(4):743-751
42. Kalisch R, Elbel GK, Gossl C, Czisch M, Auer DP (2001) Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic MRI. Neuroimage 14:891-898
43. Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7:837-844
44. Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG (2004) Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 126:591-598
45. Kretschmer BD (2000) NMDA receptor antagonist-induced dopamine release in the ventral pallidum does not correlate with motor activation. Brain Res 859:147-156
46. Krimer LS, Muly EC 3rd, Williams GV, Goldman-Rakic PS (1998) Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci 1:286-289
47. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1:199-214
48. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872
49. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455-467
50. Langsjo JW, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Sipila H, Kurki T, Silvanto M, Scheinin H (2003) Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 99:614-623
51. Langsjo JW, Salmi E, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Viljanen T, Kurki T, Silvanto M, Scheinin H (2004) Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology 100:1065-1071
52. Leslie RA, James MF (2000) Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21:314-318
53. Littlewood CL, Jones N, O'Neill MJ, Mitchell SN, Tricklebank M, Williams SCR (2005) Mapping the central effects of ketamine in the rat using pharmacological MRI. Institute of Psychiatry, King's College London
54. Liu ZM, Schmidt KF, Sicard KM, Duong TQ (2004) Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia. Magn Reson Med 52:277-285
55. Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11:81-86
56. Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA (2003) Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 117:697-706
57. MacDonald JF, Miljkovic Z, Pennefather P (1987) Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58:251-266
58. Maclver MB, Mikulec AA, Amagasu SM, Monroe FA (1996) Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology 85:823-834
59. Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A (1997) Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biol Psychiatry 42:664-668
60. Mayberg TS, Lam AM, Matta BF, Domino KB, Winn HR (1995) Ketamine does not increase cerebral blood flow velocity or intracranial pressure during isoflurane/nitrous oxide anesthesia in patients undergoing craniotomy. Anesth Analg 81:84-89
61. Mitchell SN, Greenslade RG, Cooper J (2001) LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat. Eur J Pharmacol 432:19-27
62. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927
63. Morgan CJ, Mofeez A, Brandner B, Bromley L, Curran HV (2004) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29:208-218
64. Nagase K, Iida H, Dohi S (2003) Effects of ketamine on isoflurane-and sevoflurane-induced cerebral vasodilation in rabbits. J Neurosurg Anesthesiol 15:98-103
65. Nakao S, Adachi T, Murakawa M, Shinomura T, Kurata J, Shichino T, Shibata M, Tocyama I, Kimura H, Mori K (1996) Halothane and diazepam inhibit ketamine-induced c-fos expression in the rat cingulate cortex. Anesthesiology 85:874-882
66. Nakao S, Miyamoto E, Masuzawa M, Kambara T, Shingu K (2002) Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res 926:191-196
67. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20:106-118
68. Nishizawa N, Nakao S, Nagata A, Hirose T, Masuzawa M, Shingu K (2000) The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices. Brain Res 857:188-192
69. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, Ugurbil K (1992) Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A 89:5951-5955
70. Ohata H, Iida H, Nagase K, Dohi S (2001) The effects of topical and intravenous ketamine on cerebral arterioles in dogs receiving pentobarbital or isoflurane anesthesia. Anesth Analg 93:697-702
71. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362
72. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic
73. Pearce RA, Stringer JL, Lothman EW (1989) Effect of volatile anesthetics on synaptic transmission in the rat hippocampus. Anesthesiology 71:591-598
74. Preece M, Mukherjee B, Huang CL, Hall LD, Leslie RA, James MF (2001) Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat. Brain Res 916:107-114
75. Roberts TJ (2004) Structural and functional imaging in an experimental model of Huntingtons disease - mapping pathogenesis and potential therapy. Ph.D. thesis, University of London
76. Sakai K, Cho S, Fukusaki M, Shibata O, Sumikawa K (2000) The effects of propofol with and without ketamine on human cerebral blood flow velocity and CO(2) response. Anesth Analg 90:377-382
77. Salmeron BJ, Stein EA (2002) Pharmacological applications of magnetic resonance imaging. Psychopharmacol Bull 36:102-129
78. Schwarz AJ, Zocchi A, Reese T, Gozzi A, Garzotti M, Varnier G, Curcuruto O, Sartori I, Girlanda E, Biscaro B, Crestan V, Bertani S, Heidbreder C, Bifone A (2004) Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage 23:296-304
79. Seeman P, Ko F, Tallerico T (2005) Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10(9):877-883
80. Sharp FR, Tomitaka M, Bernaudin M, Tomitaka S (2001) Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci 24:330-334
81. Sicard KM, Duong TQ (2005) Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. Neuroimage 25:850-858
82. Sicard K, Shen Q, Brevard ME, Sullivan R, Ferris CF, King JA, Duong TQ (2003) Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab 23:472-481
83. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143-155
84. Smith AJ, Pekoe GM, Monroe PJ, Martin LL, Cabrai MEY, Crisp T (1990) Ketamine analgesia in rats may be mediated by an interaction with opiate receptors. In: Domino EF (ed) Status of ketamine in anesthesiology. Ann Arbor, pp 199-209
85. Smith AT, Williams AL, Singh KD (2004) Negative BOLD in the visual cortex: evidence against blood stealing. Hum Brain Mapp 21:213-220
86. Steward CA, Prior MJW, Chapman V, Morris PG, Marsden CA (2004) Mapping functional changes in rat brain in response to altered serotonergic function using BOLD fMRI. Proceedings (12th) of the International Society of Magnetic Resonance in Medicine, pp 1169
87. Svensson TH (2000) Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Brain Res Rev 31:320-329
88. Thomas CG, Harshman RA, Menon RS (2002) Noise reduction in BOLD-based fMRI using component analysis. Neuroimage 17:1521-1537
89. Wong BS, Martin CD (1993) Ketamine inhibition of cytoplasmic calcium signalling in rat pheochromocytoma (PC-12) cells. Life Sci 53:PL359-PL364
90. Worsley KJ, Friston KJ (1995) Analysis of fMRI time-series revisited - again. Neuroimage 2:173-181
91. Xu H, Li SJ, Bodurka J, Zhao X, Xi ZX, Stein EA (2000) Heroin-induced neuronal activation in rat brain assessed by functional MRI. Neuroreport 11:1085-1092